000946151 000__ 02841cam\a2200493M\\4500
000946151 001__ 946151
000946151 005__ 20230306152533.0
000946151 006__ m\\\\\o\\d\\\\\\\\
000946151 007__ cr\un\nnnunnun
000946151 008__ 201112s2020\\\\sz\b\\\\o\\\\\001\0\eng\d
000946151 019__ $$a1205607002$$a1206402222$$a1225199462$$a1225544264$$a1225934900$$a1226288373$$a1227309200$$a1227400731
000946151 020__ $$a9783030578145$$q(electronic book)
000946151 020__ $$a3030578143$$q(electronic book)
000946151 020__ $$z3030578135
000946151 020__ $$z9783030578138
000946151 0247_ $$a10.1007/978-3-030-57814-5$$2doi
000946151 035__ $$aSP(OCoLC)on1225562882
000946151 035__ $$aSP(OCoLC)1225562882
000946151 040__ $$aSFB$$beng$$erda$$cSFB$$dOCLCO$$dLEATE$$dEBLCP$$dYDXIT$$dOCLCF$$dGW5XE$$dYDX$$dUPM$$dOHX$$dUX1$$dOCLCO
000946151 049__ $$aISEA
000946151 050_4 $$aRM301.25$$b.Z36 2020
000946151 08204 $$a615.1/9$$223
000946151 1001_ $$aZanders, Edward D.,$$eauthor.
000946151 24514 $$aThe science and business of drug discovery :$$bdemystifying the jargon /$$cEdward D. Zanders.
000946151 250__ $$aSecond edition.
000946151 264_1 $$aCham, Switzerland :$$bSpringer,$$c[2020]
000946151 300__ $$a1 online resource
000946151 336__ $$atext$$btxt$$2rdacontent
000946151 337__ $$acomputer$$bc$$2rdamedia
000946151 338__ $$aonline resource$$bcr$$2rdacarrier
000946151 347__ $$atext file$$2rdaft$$0http://rdaregistry.info/termList/fileType/1002
000946151 504__ $$aIncludes bibliographical references and index.
000946151 5050_ $$aIntroduction -- PART 1: How Drugs are Discovered and Developed in the Pharmaceutical Industry -- Introduction to Drugs and Drug Targets -- Background to chemistry of small and large molecules -- Laying the foundations- Drug discovery from antiquity to the twenty first century -- Part II-The drug development pipeline - discovery to testing in humans -- Drug discovery pipeline overview -- Target discovery -- Medicinal chemistry -- Biotherapeutics -- Screening for hits -- Process chemistry and formulation -- Preclinical development -- Part III-The drug development pipeline - clinical trials to marketing authorisation -- Clinical trials -- Regulatory affairs and marketing approval -- Diagnostics and personalized medicine -- Putting it All Together: a drug development case history -- Part IV- The Global Pharmaceuticals Business -- Commercial aspects of drug development -- Challenges and responses -- Part V -- Professional Interactions with the Drug Discovery Industry.-Professional Interactions with the Drug Discovery Industry: Technology Transfer Executives -- Recruitment Executives -- Pharmaceutical translators and Interpreters.
000946151 506__ $$aAccess limited to authorized users.
000946151 5880_ $$aOnline resource; title from PDF title page (SpringerLink, viewed January 28, 2021).
000946151 650_0 $$aDrug development$$vTerminology.
000946151 650_0 $$aPharmaceutical industry$$vTerminology.
000946151 650_0 $$aPharmaceutical technology.
000946151 650_0 $$aChemistry, Physical and theoretical.
000946151 77608 $$iPrint version:$$z3030578135$$z9783030578138$$w(OCoLC)1178894764
000946151 852__ $$bebk
000946151 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-030-57814-5$$zOnline Access$$91397441.1
000946151 909CO $$ooai:library.usi.edu:946151$$pGLOBAL_SET
000946151 980__ $$aEBOOK
000946151 980__ $$aBIB
000946151 982__ $$aEbook
000946151 983__ $$aOnline
000946151 994__ $$a92$$bISE